You just read:

Lexicon Pharmaceuticals Reports Positive Top-Line Results In Phase 3 inTandem3 Study For Sotagliflozin In Patients With Type 1 Diabetes

News provided by

Lexicon Pharmaceuticals, Inc.

Jun 09, 2017, 07:01 ET